The family histories of individuals affected by a wide variety of cancers have provided information about the principal features of hereditary cancer. Surveillance protocols, indicating the most appropriate modalities and the age at which to initiate them, have been derived from what has been learne
Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers
β Scribed by Giorgia Randi; Claudio Pelucchi; Eva Negri; Renato Talamini; Carlotta Galeone; Silvia Franceschi; Carlo La Vecchia
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 77 KB
- Volume
- 121
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Family history of urogenital cancers has been associated with an increased risk of cancer at the same sites. To evaluate the risks of bladder, prostate and renal cell neoplasms for family history of urogenital cancers in firstβdegree relatives, we analysed data from a caseβcontrol study conducted in northern Italy between 1985 and 1992 and including a total of 1,356 incident, histologically confirmed cancer cases: 727 bladder, 348 renal cell and 281 prostate cancer cases. Controls were 1,067 patients admitted to the same network of hospitals for acute, nonneoplastic conditions. Unconditional logistic regression was used to estimate odds ratios (ORs) of urogenital cancers, adjusting for age, sex, study centre, education, body mass index, smoking habit, alcohol consumption and number of brothers and, where appropriate, sisters. ORs of urogenital cancers for subjects with at least 1 firstβdegree relative with cancer at the same site were 6.1 [95% confidence interval (CI), 2.3β16.6] for bladder, 2.0 (95% CI: 0.6β6.2) for renal cell and 2.0 (95% CI: 0.9β4.1) for prostate cancer. Β© 2007 WileyβLiss, Inc.
π SIMILAR VOLUMES
Prostate cancer occurs more frequently in U.S. blacks than whites. A population-based case-control study which investigated the association with family history of cancer was carried out among 98 I men (479 black, 502 white) with pathologically confirmed prostate cancer, diagnosed between August I, 1
## Abstract Genetic factors may be used not only to assess risk of prostate cancer development but also to evaluate prostate cancer outcomes including clinical prognosis, treatment methods, and treatment response. To assess the role of family history on prostate cancer outcomes, we evaluated tumor
## Abstract Prostate cancer family history has been associated with increased risk of the malignancy. Most prior studies have been retrospective and subject to recall bias, however, and data evaluating interactions with other important risk factors are limited. We examined the relationship between